Results 291 to 300 of about 106,180 (310)
Some of the next articles are maybe not open access.

Eosinophilic Esophagitis

Annals of Internal Medicine, 2003
Eosinophilic esophagitis is a new disease commonly confused with gastroesophageal reflux disease. Because of different treatments, recognition of eosinophilic esophagitis is important.Recent work further characterizes the allergic response, demonstrating a population of eosinophils different from gut and blood that specifically homes to the esophagus ...
Jonathan E, Markowitz   +1 more
openaire   +8 more sources

Diagnostic Delay in Patients With Eosinophilic Esophagitis Has Not Changed Since the First Description 30 Years Ago: Diagnostic Delay in Eosinophilic Esophagitis

American Journal of Gastroenterology, 2022
INTRODUCTION: Eosinophilic esophagitis (EoE) is a chronic progressive disease. Diagnostic delay (DD) is associated with increased risk of esophageal strictures and food impactions. We aimed to assess the evolution of DD since the first description of EoE
F. Murray   +11 more
semanticscholar   +1 more source

Characterization of Eosinophilic Esophagitis From the European Pediatric Eosinophilic Esophagitis Registry (pEEr) of ESPGHAN

Journal of Pediatric Gastroenterology and Nutrition - JPGN, 2022
Objectives: Few pediatric data on phenotypic aspects of eosinophilic esophagitis (EoE) are available. The pEEr registry was developed to prospectively characterize children with EoE from Europe and Israel. Methods: pEEr is an ongoing prospective registry
S. Oliva   +23 more
semanticscholar   +1 more source

Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).

Journal of Pediatric Gastroenterology and Nutrition - JPGN
INTRODUCTION Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus characterized by symptoms of esophageal dysfunction and histologically by predominantly eosinophilic infiltration of the squamous epithelium.
J. Amil-Dias   +28 more
semanticscholar   +1 more source

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.

New England Journal of Medicine
BACKGROUND Benralizumab is an eosinophil-depleting anti-interleukin-5 receptor α monoclonal antibody. The efficacy and safety of benralizumab in patients with eosinophilic esophagitis are unclear.
M. Rothenberg   +15 more
semanticscholar   +1 more source

Current treatment options and long-term outcomes in patients with eosinophilic esophagitis

Expert Review of Clinical Immunology, 2022
Introduction Dietary and pharmacological (proton pump inhibitors, swallowed topical corticosteroids) therapies are effective for induction of clinical and histological remission of eosinophilic esophagitis.
A. Lucendo, J. Molina-Infante
semanticscholar   +1 more source

Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians

Expert Review of Gastroenterology & Hepatology, 2020
Introduction The rapid expansion in the epidemiology of eosinophilic esophagitis (EoE) is being documented, along with cumulative research assessing environmental exposures associated with EoE and susceptibility due to genetic variants.
Á. Arias, A. Lucendo
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy